An overview of the research history and current evidence on psychedelics and psychedelic-assisted therapy. It covers LSD, MDMA, psilocybin, and ketamine, with attention to clinical trials, therapeutic uses, and how this work fits into modern mental health care.
Portland Psychotherapy
English
This course provides a concise survey of research on psychedelics and psychedelic-assisted therapy, beginning with early LSD studies in the 1950s and 1960s and the later halt in psychedelic research in the early 1970s. It also explains how interest in the field has increased over the last decade through new clinical trials and emerging applications in mental health treatment. The content covers MDMA-assisted therapy for PTSD, psilocybin-assisted therapy for depression and end-of-life distress, and ketamine’s role in depression treatment. It also references trial phases, breakthrough therapy status, and examples of outcomes reported in the source text. This material is intended for learners seeking a research-based overview of psychedelic medicine, including students, clinicians, and others interested in the evidence base behind current and emerging treatments. The source does not specify a detailed course format, duration, or assessment structure.
Students, clinicians, and others interested in the research evidence behind psychedelic medicine and psychedelic-assisted therapy.
Portland Psychotherapy is a Portland, Oregon clinic, research, and training center that integrates psychedelic science into evidence-based clinical practice, conducting clinical trials of MDMA-assisted therapy for social anxiety disorder and offering psychedelic integration services. Their distinctive model funds peer-reviewed research through clinical revenue, resulting in exceptionally well-trained therapists in psychedelic-assisted care.
By Ketamine Academy
Spravato FastTrack is an implementation course for clinics that want to add Spravato (esketamine) services. It covers REMS certification, procurement, prior authorization, billing, documentation, and related operational steps.
By Double Blind
This article examines how ketamine clinics may serve as a model for future legal psychedelic therapy, especially for MDMA and psilocybin. It compares clinic models, regulation, and the role of psychotherapy in treatment delivery.
By CIIS
A 12-month certificate in psychedelic-assisted therapies and research offered by CIIS. The program includes hybrid or online study and covers clinical competencies, research, cultural context, and ethical practice.
Next cohort: Jun 1, 2026